189 related articles for article (PubMed ID: 34019335)
1. Pediatric myelodysplastic syndrome with inflammatory manifestations: Diagnosis, genetics, treatment, and outcome.
Yanir AD; Krauss A; Stein J; Steinberg-Shemer O; Gilad O; Lotan SN; Dgany O; Krasnov T; Kodman Y; Feuerstein T; Mardoukh J; Fishman H; Geron I; Yacobovich J; Tamary H; Birger Y; Avrahami G; Izraeli S; Birenboim SB
Pediatr Blood Cancer; 2021 Oct; 68(10):e29138. PubMed ID: 34019335
[TBL] [Abstract][Full Text] [Related]
2. [Juvenile myelomonocytic leukemia and pediatric myelodysplastic syndromes].
Strullu M; Leblanc T; Lainey E
Bull Cancer; 2023 Nov; 110(11):1183-1195. PubMed ID: 37453833
[TBL] [Abstract][Full Text] [Related]
3. DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.
Flotho C; Sommer S; Lübbert M
Semin Cancer Biol; 2018 Aug; 51():68-79. PubMed ID: 29129488
[TBL] [Abstract][Full Text] [Related]
4. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
Niemeyer CM; Kratz CP
Br J Haematol; 2008 Mar; 140(6):610-24. PubMed ID: 18302710
[TBL] [Abstract][Full Text] [Related]
5. Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia.
Loh ML
Hematology Am Soc Hematol Educ Program; 2010; 2010():357-62. PubMed ID: 21239819
[TBL] [Abstract][Full Text] [Related]
6. [Clinical features and prognosis of juvenile myelomonocytic leukemia: an analysis of 63 cases].
Yang WY; Liu LP; Liu F; Qi BQ; Chang LX; Zhang L; Chen XJ; Zou Y; Chen YM; Guo Y; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):265-271. PubMed ID: 36946161
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of juvenile myelomonocytic leukemia.
Sakashita K; Matsuda K; Koike K
Pediatr Int; 2016 Aug; 58(8):681-90. PubMed ID: 27322988
[TBL] [Abstract][Full Text] [Related]
8. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia with intestinal Behçet's disease: A case report.
Liu C; Fu C; Guo X; Rong L; Li J; Fang Y
Int J Rheum Dis; 2024 Jan; 27(1):e14882. PubMed ID: 37771000
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation for Behçet's disease: a case report and systematic review of the literature.
Soysal T; Salihoğlu A; Esatoğlu SN; Gültürk E; Eşkazan AE; Hatemi G; Hatemi I; Öngören Aydın Ş; Erzin YZ; Başlar Z; Tüzüner N; Ferhanoğlu B; Çelik AF
Rheumatology (Oxford); 2014 Jun; 53(6):1136-41. PubMed ID: 24505123
[TBL] [Abstract][Full Text] [Related]
11. Array-CGH as an adjuvant tool in cytogenetic diagnosis of pediatric MDS and JMML.
Silva AG; Maschietto M; Vidal DO; Peliçario LM; Velloso ED; Lopes LF; Krepischi AC; Rosenberg C
Med Oncol; 2013 Dec; 30(4):734. PubMed ID: 24085545
[TBL] [Abstract][Full Text] [Related]
12. [Genetic characteristics and survival analysis of 27 cases of juvenile myelomonocytic leukemia].
Li JJ; Hu T; Li JH; Zhang ZX; Feng SQ; Shi XD; Zhang L; Cao J; Song ZL; Hu MZ; Zhong DX; Yue M; Fan W; Tang RH; Zou BH; Liu R
Zhonghua Er Ke Za Zhi; 2023 Jan; 61(1):56-60. PubMed ID: 36594122
[No Abstract] [Full Text] [Related]
13. Myelodysplastic and myeloproliferative disorders of childhood.
Hasle H
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):598-604. PubMed ID: 27913534
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy in juvenile myelomonocytic leukemia: Where are we now?
De Vos N; Hofmans M; Lammens T; De Wilde B; Van Roy N; De Moerloose B
Pediatr Blood Cancer; 2022 Nov; 69(11):e29930. PubMed ID: 36094370
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of juvenile myelomonocytic leukemia in the blast crisis phase treated by acute myeloid leukemia-oriented chemotherapy and allogeneic hematopoietic stem cell transplantation.
Ueda S; Sakata N; Muramatsu H; Sakaguchi H; Wang X; Xu Y; Kojima S; Yamaguchi T; Higa T; Takemura T
Int J Hematol; 2014 Nov; 100(5):502-6. PubMed ID: 25047104
[TBL] [Abstract][Full Text] [Related]
16. Therapy-related myeloid neoplasms resembling juvenile myelomonocytic leukemia: a case series and review of the literature.
Wintering A; Smith S; Fuh B; Rangaswami A; Dahl G; Chien M; Gruber TA; Dang J; Li LS; Lenzen A; Savelli S; Dvorak CC; Agrawal AK; Stieglitz E
Pediatr Blood Cancer; 2022 May; 69(5):e29499. PubMed ID: 34939322
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8.
Konuma T; Miyazaki Y; Uchida N; Ohashi K; Kondo T; Nakamae H; Takahashi S; Mori T; Ozawa Y; Kato C; Iwato K; Fukuda T; Ichinohe T; Atsuta Y; Ishiyama K;
Biol Blood Marrow Transplant; 2017 Jan; 23(1):75-80. PubMed ID: 27777139
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia: the Brazilian experience in the past decade.
Valera ET; Latorre Mdo R; Mendes WL; Seber A; Lee ML; de Paula MJ; Loggetto SR; Velloso E; Niero-Melo L; Lopes LF;
Leuk Res; 2004 Sep; 28(9):933-9. PubMed ID: 15234570
[TBL] [Abstract][Full Text] [Related]
19. [Juvenile myelomonocytic leukemia (JMML): recent advances in molecular pathogenesis and treatment].
Sakashita K
Rinsho Ketsueki; 2016 Feb; 57(2):137-46. PubMed ID: 26935631
[TBL] [Abstract][Full Text] [Related]
20. Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.
Chang TY; Dvorak CC; Loh ML
Blood; 2014 Oct; 124(16):2487-97. PubMed ID: 25163700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]